| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 43,93% | 77,63% | 55,81% | · |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) Q-ACC | RVI TECNOLOGÍA | 24,58% | 74,11% | 55,81% | 405,85% |
| CAPITAL GROUP EUROPEAN CORE EQUITY FUND (LUX) Z EUR | RVI EUROPA VALOR | 18,05% | 43,72% | 55,80% | 116,69% |
| BLACKROCK SYSTEMATIC ASIA PACIFIC EQUITY ABSOLUTE RETURN A2 EUR HEDGED | RENT. ABSOLUTA. | 6,10% | 41,15% | 55,79% | · |
| CT (LUX) AMERICAN EXTENDED ALPHA 3U USD | RENT. ABSOLUTA. | 26,89% | 58,30% | 55,79% | · |
| AMUNDI FUNDS US EQUITY RESEARCH E2 EUR (C) | RVI USA | 22,62% | 46,56% | 55,78% | · |
| MFS MERIDIAN EUROPEAN RESEARCH FUND IH1-USD | RVI EUROPA | 22,79% | 33,86% | 55,78% | 163,06% |
| SCHRODER ISF EMERGING MARKETS X2 ACC USD | RVI EMERGENTES | 39,33% | 85,41% | 55,78% | · |
| SPDR STOXX EUROPE 600 SRI UCITS ETF ACC | RVI EUROPA | 19,07% | 46,86% | 55,77% | · |
| JANUS HENDERSON HF - JAPAN OPPORTUNITIES H2 USD | RVI JAPÓN | 31,24% | 57,58% | 55,76% | 155,68% |
| SABADELL EUROACCION, FI PYME | RV EURO | 19,39% | 44,59% | 55,76% | 95,03% |
| WELLINGTON GLOBAL RESEARCH EQUITY D USD ACC | RVI GLOBAL | 20,37% | 54,86% | 55,75% | · |
| AMUNDI FUNDS US EQUITY RESEARCH A EUR (C) | RVI USA | 22,62% | 46,50% | 55,74% | · |
| IBERCAJA JAPON, FI A | RVI JAPÓN | 40,24% | 71,45% | 55,74% | 168,33% |
| CAPITAL GROUP INVESTMENT COMPANY OF AMERICA (LUX) BH EUR | RVI USA | 7,38% | 60,96% | 55,73% | 154,23% |
| BNP PARIBAS EASY MSCI EUROPE MIN TE TRACK PRIVILEGE CAP | RVI EUROPA | 18,48% | 48,84% | 55,71% | · |
| CT (LUX) AMERICAN EXTENDED ALPHA 8E EUR | RENT. ABSOLUTA. | 27,07% | 58,69% | 55,70% | · |
| JPM JAPAN EQUITY D (ACC) EUR (HEDGED) | RVI JAPÓN | 18,12% | 83,76% | 55,70% | 237,96% |
| RBC FUNDS (LUX)-EMERGING MARKETS EQUITY FUND A CAP USD | RVI EMERGENTES | 32,15% | 61,05% | 55,70% | 112,84% |
| VANGUARD FTSE DEVELOPED EUROPE EX UK UCITS ETF EUR ACC | RVI EUROPA EX-UK | 19,43% | 50,41% | 55,69% | · |
